Rafarma Pharmaceuticals (Laskavy Patent) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Rafarma Pharmaceuticals (Laskavy Patent) General Information
Description
Portfolio of medicinal patent right in the United States. The asset offers the company access to several new technologies including the new generation immune modulator XR.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Primary Office
- United States
Rafarma Pharmaceuticals (Laskavy Patent) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|